Preclinical safety and efficacy of andexanet alfa in animal models

ConclusionsThese data suggest that andexanet is a promising therapy for the reversal of FXa inhibitor‐induced anticoagulation, supporting clinical studies in humans.This article is protected by copyright. All rights reserved.

Source: Journal of Thrombosis and Haemostasis - July 1, 2017 Category: Hematology Authors: G. Lu, S. J. Hollenbach, D. C. Baker, S. Tan, A. Hutchaleelaha, J. T. Curnutte, P. B. Conley Tags: Original Article ‐ Clinical Haemostasis and Thrombosis Source Type: research